Corinne Le Goff joins CFAO’s Supervisory Board
CFAO announced today the appointment of Corinne Le Goff as a member of CFAO’s Supervisory Board effective from October 28, 2014....
She succeeds Kiyoshi Yamakawa who resigned from his office. Corinne Le Goff, who is currently President of Roche S.A.S, pharmaceuticals subsidiary of Roche in France, has also been appointed as a member of two out of four specialized Committees: the Nomination and Compensation Committee and the Sustainable Development Committee. Her appointment will be subject to the approval of the General Shareholders' Meeting scheduled for June 12, 2015.
The Supervisory Board is chaired by Jean-Charles Pauze and also comprises Pierre Guénant (Vice-Chairman), Yasuhiko Yokoi, Takashi Hattori, Sylvie Rucar and Nathalie Delapalme.
Corinne Le Goff, 49 years old, has an in-depth knowledge of the pharmaceutical industry gained during her 25-year professional career working for different large leading companies in the pharmaceutical and biotechnology sectors where she held different functions and important positions. Before joining the Roche group she was Senior VP Strategy and Global Marketing Neurology & Rheumatology at Merck-Serono and VP Empowered Regions Commercial Operations at Sanofi-Aventis in the USA.
Corinne Le Goff earned a Pharm.D from the University of Paris Descartes and a Master’s degree from the University Panthéon Sorbonne. She then completed her education with studies at different Business Schools in France and abroad.
Go to top